-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

722. Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II

Symposia: Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 10, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Divya Koura, MD1, James Mirocha, MS2*, Kaitlyn C Dykes, MD1*, Ayad Hamdan1*, Aaron Goodman, MD1, Tiffany N Tanaka, MD1, Carolyn M. Mulroney, MD1, Caitlin L. Costello, MD1, James K. Mangan, MD1, Edward D. Ball, MD3, Ah-Reum Jeong, MD1, Joseph Maroge1*, Michelle Padilla1* and Dimitrios Tzachanis, MD, PhD4

1UCSD Moores Cancer Center, La Jolla, CA
2Samuel Oschin Comprehensive Cancer Institute, Clinical and Translational Science Institute (CTSI), Los Angeles, CA
3Division of Bone and Marrow Transplantation, Department of Medicine, Moores Cancer Center, University of California, San Diego, La Jolla, CA
4UCSD Moores Cancer Center, Carlsbad, CA

Rodney A. Sparapani, PhD1*, Martin J. Maiers, MS2*, Stephen R. Spellman, MBS3*, Bronwen E. Shaw, PhD, MRCP, FRCPath4,5, Purushottam W. Laud, PhD6*, Steven M. Devine, MD2, Caitrin Bupp, MPH2*, Meilun He, MPH2* and Brent R. Logan, PhD4,6*

1Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI
2CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis
3CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN
4CIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee
5Department of Medicine, Medical College of Wisconsin, Milwaukee
6Division of Biostatistics, Medical College of Wisconsin, Milwaukee

Florent Malard, MD, PhD1*, Michael Loschi, MD2*, Thomas Cluzeau, MD, PhD3, Faezeh Legrand, MD4*, Jean-Baptiste Méar, MD5*, Faustine Lhomme, MD6*, Anne Huynh, MD7*, Sarah Guenounou, MD8*, Cécile Borel, MD9*, Déborah Desmier, MD10*, Niels Moya, MD11*, Amandine Charbonnier, MD12*, Delphine Lebon13*, Hélène Labussière-Wallet14*, Corentin Orvain15*, Sylvain Chantepie, MD16*, Martin Carre, MD17*, Vincent Camus, MD18*, Marie-Anne Couturier, MD19*, Jérôme Cornillon, MD20*, Patrice Chevallier, MD21, Clemence Mediavilla, MD22*, Patrice Ceballos, MD23*, David Beauvais, MD24*, Etienne Daguindau, MD25*, Karin Bilger, MD26*, Stefan Klein, MD27*, Marion Bruelle, PhD28*, Emilie Plantamura, PhD, MSc, PharmD29* and Mohamad Mohty, MD, PhD30

1Department of Clinical Hematology and Cellular Therapy, Sorbonne University, Saint Antoine Hospital, Assistance Publique - Hôpitaux de Paris, INSERM UMRs 938, Centre de Recherche Saint-Antoine (CRSA), Paris, France
2Service d’hématologie, CHU de Nice, Nice, France
3Nice University Hospital, Nice, Provence Alpes Cote d'Azur, France
4Hematology department, Institut Paoli calmettes, Marseille, FRA
5University Hospital of Rennes, Clinical hematology, Rennes, France
6Clinical Hematology, University Hospital of Rennes, RENNES, France
7Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
8CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
9Hematology department, IUCT Oncopole, Toulouse, France
10Poitiers Hospital, Poitiers, FRA
11CHU Poitiers, Poitiers, France
12Service d’Hématologie Clinique, Centre Hospitalier Universitaire Amiens-Picardie, Amiens, France
13Hematology Department, CHU Amiens, Amiens, France
14Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France
15Hematology Department, Angers University Hospital, Angers, France
16Institut d'Hématologie, CHU de Caen, Caen, France
17Clinical Hematology Department, CHU Grenoble Alpes - Université Grenoble Alpes, Grenoble, France
18Department of Hematology, Centre Henri Becquerel, Rouen, France
19CHU Brest, BREST, France
20Département d’hématologie clinique et de thérapie cellulaire, CHU de St-Étienne, Saint-Étienne, France
21Service d'hématologie, CHU de Nantes, Nantes, France
22Hopital Haut-Leveque, Bordeaux, France
23Clinical Hematology Department, Montpellier University Hospital, MONTPELLIER, France
24Allograft department, CHRU Lille, Lille, France
25Department of Clinical Hematology, Hopital Jean Minjoz, Service d`Hématologie, Besançon, France
26Hematology, Institut de Cancerologie Strasbourg Europe (ICANS), Strasbourg, France
27Medizinische Klinik Hämatologie und Onkologie Universitätsmedizin, Mannheim, Germany
28MaaT Pharma, Lyon, France
29MaaT Pharma, LYON, France
30Saint-Antoine Hospital, Sorbonne University, Paris, France

Huiying Qiu1*, Qiaomei He1*, Xi Sun1*, Ying Wang2*, Jiahua Niu1*, Jun Yang1*, Chongmei Huang1*, Kun Zhou1*, Yin Tong1*, Yu Cai1*, Baoxia Dong1*, Liping Wan1* and Xianmin Song, phd1

1Department of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2Clinical Research & Development, Jiangsu Hengrui pharmaceuticals Co., Ltd., Shanghai, China

Larisa Shelikhova, MD1*, Margarita Perminova, MD2*, Olga Molostova, MD3*, Maria Ilushina, MD2*, Rimma Khismatullina, MD2*, Dmitriy Balashov, MD2*, Natalia Miakova, MD2*, Julia Skvortsova, MD4*, Maria Dunaikina, MD3*, Svetlana Radygina, MD2*, Galina Novichkova, MD2*, Svetlana Kozlovskaya, MD2*, Sergei Blagov, MD2*, Elena Kurnikova, MD2*, Anna Livshits, MD2*, Dmitriy Pershin, MD2*, Dmitriy Litvinov, MD2*, Alexey Maschan, MD, DSc1* and Michael Maschan, MD, MSc5

1Dmitriy Rogachev National Medical Center of Pediatric Hematology, Oncology and Immunology, Moscow, RUS
2Dmitriy Rogachev National Medical Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation
3Dmitriy Rogachev National Medical Research Centre of Pediatric Hematology, Oncol, Moscow, Russian Federation
4Dmitriy Rogachev National Medical Center of Pediatric Hematology, Oncology and I, Moscow, Russian Federation
5Dmitriy Rogachev National Medical Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia

Han Yao, MD1*, Xiaoqi Wang, MD1*, Ruihao Huang, PhD student1*, Haixia Fu, MD2*, Ren Lin3*, Yimei Feng1*, Xiaojuan Deng1*, Ting Chen1*, Lidan Zhu1*, Jia Liu1*, Yuqing Liu1*, Lu Zhao1*, Lu Wang1*, Cheng Zhang1*, Peiyan Kong1*, Li Gao1*, Lei Gao1*, Qifa Liu, MD3, Xiaohui Zhang2* and Xi Zhang, PhD1

1Army medical University affiliated Xinqiao Hospital, Chongqing, China
2Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China
3Nanfang Hospital, Southern Medical University, Guangzhou, China

Salim Oulghazi, MD1*, Leonard Petry2*, Mark E Robinson, PhD3*, Richard Huth4*, Caroline Pabst5*, Peter Dreger, MD6 and Thomas Luft, MD, PhD7*

1Center of Molecular and Cellular Oncology, Yale University, New Haven, CT
2University Hospital Heidelberg, Heidelberg, Germany
3Yale University, Boston, CT
4Department of Medicine V, Hematology, Oncology and Rheumatology, University Hosp, Heidelberg, DEU
5University Hospital Heidleberg, Heidelberg, DEU
6Universitätsklinikum, Heidelberg, Germany
7University of Heidelberg, Heidelberg, Germany

Olaf Penack, MD1*, Mouad Abouqateb2*, Christophe Peczynski3*, William Boreland3*, Nicolaus Kröger, MD4*, Matthias Stelljes, MD5, Tobias Gedde-Dahl, MD6*, Igor Wolfgang Blau, MD, PhD7*, Thomas Schroeder8*, Urpu Salmenniemi9*, Aleksandr Kulagin Sr.10*, Regis Peffault De Latour11*, Stephan Mielke, MD12, Jürgen Finke, MD13, Ivan Sergeevich Moiseev, MD14*, Helene Schoemans15*, Christian Koenecke, MD16 and Zinaida Peric, MD PhD17*

1Department of Hematology, Oncology, and Cancer Immunology, Charité Universitätsmedizin Berlin, Campus Virchow Klinik, Berlin, Germany
2EBMT Office, Paris, France
3EBMT Paris Study Unit, Paris, France
4University Medical Center Hamburg, Hamburg, Germany
5Universitaetsklinikum Muenster, Muenster, DEU
6Oslo University Hospital, Rikshospitalet, Clinic for Cancer Medicine, Hematology Department, Section for Stem Cell Transplantation, Oslo, Norway
7Medizinische Klinik m. S. Hämatologie, Onkologie und Tumorimmunologie, Berlin, Germany
8Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany
9Dept of Hematology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland
10b. First State Pavlov Medical University of St. Petersburg, Raisa Gorbacheva Memorial Research Institute for Paediatric Oncology, Hematology, and Transplantation, St-Petersburg, Russia, St. Petersburg, RUS
11Hôpital Saint-Louis,, Paris, France
12Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Institute & University Hospital, Stockholm, Stockholms Laen, Sweden
13Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany
14RM Gorbacheva Research Institute, Pavlov University, Saint-Petersburg, Russian Federation
15University Hospitals Leuven and KU Leuven, Leuven, Belgium
16Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, NDS, Germany
17University of Zagreb, Zagreb, Croatia

Bo Wan, MD1, Yasser Abou Mourad, MD, FRCPC, FACP2*, Shanee Chung, FRACP, FRCPA, FRCPC3, Donna L. Forrest, MD, FRCPC2, Florian Kuchenbauer, MD, PhD, FRCPC4, Stephen H. Nantel, MD, FRCPC2, Sujaatha Narayanan, MBBS, MRCP, MRCPath2*, Thomas J. Nevill, MD, FRCPC2, Maryse Power, MD, FRCPath5, Judith Anula Rodrigo, MD, FRCPC2*, David Sanford, MD, FRCPC6, Kevin Song, MD, FRCPC2, Ryan J Stubbins, MD, MSc, FRCPC2, Heather J. Sutherland, MD, PhD, FRCPC7, Cynthia L. Toze, MD, MSc, FRCPC2, Jennifer White, MD, MSc, FRCPC2*, Claudie Roy, MD, FRCPC5* and Kevin A Hay, MD, MSc, FRCPC5

1University of British Columbia, Vancouver, BC, Canada
2University of British Columbia, Vancouver, Canada
3Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver, Canada
4BC Cancer Research Centre, Vancouver, BC, Canada
5Leukemia/Bone Marrow Transplant Program of British Columbia, University of British Columbia, Vancouver, BC, Canada
6Leukemia/Bone Marrow Transplant Program of BC, British Columbia Cancer Agency, University of British Columbia, Vancouver, BC, Vancouver, Canada
7University of British Columbia, Vancouver, BC, CAN

Alejandro Villar-Prados, MD, PhD1, Everett H. Meyer, MD, PhD2, Katherine Sutherland, PA-C3*, Robert S. Negrin, MD4, Sally Arai, MD5, Matthew J. Frank, MD, PhD6, Laura Johnston7, Robert Lowsky, MD8*, David B. Miklos, MD, PhD6, Lori S. Muffly, MD9, Saurabh Dahiya6*, Andrew R. Rezvani, MD, BA10*, Surbhi Sidana, MD7, Parveen Shiraz, MD7*, Judith Shizuru, MD, PhD11*, Wen-Kai Weng, MD, PhD6, Melody Smith, MD, MS12, Sushma Bharadwaj, MD, MS6, John Tamaresis, PhD13*, Anna Pavlova, MD/PhD14* and Scott McClellan14*

1Division of Hematology, Department of Medicine, Stanford University School of Medicine, Sunnyvale, CA
2Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University Medical Center, Stanford, CA
3Stanford University, Stanford
4Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA
5Stanford University Medical Center, Palo Alto, CA
6Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Palo Alto, CA
7Stanford University, Stanford, CA
8Stanford Univ. Med. Ctr., Stanford, CA
9Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA
10Stanford University Cancer Institute, Palo Alto, CA
11Stanford U Med Ctr, Stanford, CA
12Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Stanford, CA
13Department of Biomedical Data Science, Stanford University, Stanford, CA
14Orca Bio, Menlo Park

Makoto Iwasaki, MD, PhD1*, Junya Kanda, MD, PhD2*, Fumihiko Kimura, MD, PhD3, Sachiko Seo, MD, PhD4, Yoshiko Atsuta, MD, PhD5*, Naoyuki Uchida, MD, PhD6, Noriko Doki, MD, PhD7, Takahiro Fukuda, MD, PhD8*, Tetsuya Nishida, MD, PhD9*, Yuta Katayama, MD, PhD10, Masatsugu Tanaka, M.D., Ph.D.11*, Tetsuya Eto, MD, PhD12*, Kazuhiro Ikegame, MD, PhD13*, Yoshinobu Kanda14*, Masashi Sawa, MD, PhD15*, Makoto Onizuka, MD, PhD16, Moeko Hino, MD, PhD17*, Tatsuo Ichinohe, M.D.Ph.D.18, Ken Tabuchi, MD, PhD19* and Akifumi Takaori-Kondo, MD, PhD20

1Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Nara, NAR, Japan
2Department of Hematology, Kyoto University Hospital, Kyoto, Japan
3Division of Hematology, National Defense Med. College, Tokorozawa, JPN
4Department of Hematology and Oncology, Dokkyo Medical University,, Tochigi, JPN
5Japanese Data Center For Hematopoietic Cell Transplantation, Nagakute, Japan
6Department of Hematology, Toranomon Hospital, Tokyo, Japan
7Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
8Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
9Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan
10Department of Hematology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan
11Department of Hematology, Kanagawa Cancer Center, Kanagawa, Japan
12Department of Hematology, Hamanomachi Hospital, Fukuoka, JPN
13Department of Hematology, Hyogo Medical University Hospital, Nishinomiya, Japan
14Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan
15Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan
16Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan
17School of Medicine, Chiba University, Chiba, Japan
18Research Institute For Radiation Biology and Medicine, Hiroshima, Japan
19Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan
20Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

Lorenzo Iovino, MD, PhD1,2, Jessica Lok2*, Jacqueline Diaz2*, Heather Persinger2*, Vanessa A Hernandez3*, Kirsten Cooper3*, Paul Deroos3*, David Granadier, BS2,4*, Dante Dennis Acenas II, BA4,5, Jarrod A Dudakov, PhD6 and Marie Bleakley, PhD, MBBS, MMSc3,7

1University of Washington School of Medicine, Seattle, WA
2Fred Hutchinson Cancer Center, Seattle, WA
3Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle, WA
4University of Washington, Seattle, WA
5Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA
6Program in Immunology, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA
7Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Seattle Children's Hospital and University of Washington, Seattle, WA

Catherine J. Lee, MD1, John Phillips, PhD2*, Amy Lin, MD3,4*, Jan Pierce, MBA2*, Hailey Jensen, MStat5*, Lawrence J. Cook, PhD5* and Daniel R. Couriel, MD, MS, MBA1

1Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
2Cell Therapy and Regenerative Medicine (CellReGen), University of Utah, Salt Lake City, UT
3John A. Moran Eye Center, University of Utah Health, Salt Lake City
4Department of Ophthalmology & Visual Service, University of Utah, Salt Lake City
5Pediatric Critical Care, University of Utah, Salt Lake City, UT

Alisha Weiss-Haug, MD1*, Reka A Haraszti, MD, PhD2, Britta Merz, MD1*, Kristina Reuss, MD1*, Christoph Faul, MD1, Wolfgang Andreas Bethge, MD1*, Frederike Schwartz, MD1*, Wichard Vogel, MD1* and Claudia Lengerke, MD1

1Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany
2Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tubingen, Germany

Ruoyang Shao, MD1* and Qifa Liu, MD2

1Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
2Nanfang Hospital, Southern Medical University, Guangzhou, China

Haris Ali, MD1, Dongyun Yang, PhD2*, Sally Mokhtari, PhD3, Ahmed Aribi, MD1*, Joshua Mansour, MD1*, Firoozeh Sahebi, MD1*, Geoffrey P. Shouse, PhD, DO1, Idoroenyi Amanam, MD4, Salman Otoukesh, MD1, Anthony Stein, MD1, Stephen J. Forman, MD, FACP1, Guido Marcucci, MD1, Ryotaro Nakamura, MD1 and Monzr M. Al Malki, MD5

1Hematology/HCT, City of Hope National Medical Center, Duarte, CA
2Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA
3Clinical and Translational Project Development, City of Hope National Medical Center, Duarte
4City of Hope National Medical Center, Duarte, CA
5Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA

Federic Galaverna, MD, PhD1*, Sara Flamini, PhD1*, Ilaria Pili, MD1*, Carmen De Luca, MD1*, Emilia Boccieri, MD1*, Francesca Benini, MD2*, Francesco Quagliarella, MD1*, Marco Rosichini, MSc1*, Marialuigia Catanoso, MD1*, Marianna Coccetti, MSc3*, Shirley Genah, PhD1*, Roberto Carta, MD1*, Francesca Del Bufalo, MD, PhD1*, Valentina Bertaina, PhD1*, Marco Becilli, MD1*, Daria Pagliara, MD, PhD1*, Mattia Algeri, MD1*, Pietro Merli, MD1*, Franco Locatelli, MD, PhD1,4 and Enrico Velardi, PhD1*

1Department of Haematology-Oncology and Cell and Gene Therapy, Bambino Gesù Children Hospital, Rome, Italy
2St. Jude Children's Research Hospital, Memphis, TN
3Research Laboratory Core Facility, Bambino Gesù Children Hospital, Rome, Italy
4Catholic University of the Sacred Heart, Rome, Italy

Jingyuan Lu1*, Yanhong Zhuang1*, Xiuli Hong1*, Jie Chen1*, Yanxin Chen1*, Erlie Jiang, PhD2 and Quanyi Lu1*

1Department of Hemotology, Zhongshan Hospital Xiamen University, Xiamen, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China

Fen Huang1*, Jing Du2*, Pinjing Lv3*, Kaibo Yang4*, Zhiping Fan5*, Li Xuan6*, Jing Sun, Mphil, BEng7*, Na Xu6*, Hui Liu, MD, PhD4*, Pengcheng Shi6*, Xiaofang LI, MD1*, Jun Xu8*, Zhixiang Wang9*, Pu Wang10*, Xiang Yao11*, Ye Chen3* and Qifa Liu, MD5

1Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, CHN
2Department of Hematology, Nanfang Hospital, Southern Medical University, GUANGZHOU, CHN
3Department of Gastroenterology, Nanfang Hospital,Southern Medical University, Guangzhou, China
4Department of Hematology, Nanfang Hospital,Southern Medical University, Guangzhou, China
5Nanfang Hospital, Southern Medical University, Guangzhou, China
6Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
7Nanfang hospital of southern medical university, London, ENG, United Kingdom
8Department of Hematology,, Nanfang Hospital, Southern Medical University, Guangzhou, CHN
9Nanfang Hospital, Southern Medical University, Guangzhou, CHN
10Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, CHN
11Department of Gastroenterology,, Nanfang Hospital, Southern Medical University, Guangzhou, China

Trent Wang, DO, MPH1, Anna Crawford2*, Denggang Fu, PhD3*, Elizabeth Hill, MD3*, Antonio M. Jimenez Jimenez, MD, MSc4*, Krishna V. Komanduri, MD5 and Sophie Paczesny3

1University of Miami Miller School of Medicine/ Sylvester Comprehensive Cancer Center, Miami Springs, FL
2Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
3Medical University of South Carolina, Charleston, SC
4Sylvester Comprehensive Cancer Center, Miller School of Medicine, Miami, FL
5UCSF, San Francisco, CA

Takayuki Katagiri, MD, PhD1*, Tatuya Suwabe, MD, PhD2*, Kyoko Fuse3, Yasuhiko Shibasaki, MD, PhD4*, Jun Takizawa, MD, PhD5*, Hirohito Sone, MD, PhD4* and Masayoshi Masuko, MD, PhD3

1Department of Hematology, Niigata University Faculty of Medicine, NIIGATA-SHI CHUO-KU, NIG, Japan
2Niigata University Faculty of Medicine, NIIGATA-SHI CHUO-KU, Japan
3Department of Haematopoietic Cell Therapy, Niigata University Medical and Dental Hospital, Niigata, Japan
4Niigata University Faculty of Medicine, Niigata, Japan
5Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine, Niigata, Japan

Kristin Rathje1*, Nico Gagelmann2*, Rachel B. Salit, MD3*, Thomas Schroeder4*, Carmelo Gurnari, MD5,6, Simona Pagliuca, MD, PhD7, Victoria Panagiota, MD8*, Christina Rautenberg4*, Bruno Cassinat, PhD, PharmD9, Felicitas Thol8, Christine Wolschke2*, Marie Robin, MD, PhD10*, Michael Heuser, MD8, Marie-Thérèse Rubio, MD, PhD11*, Jaroslaw P. Maciejewski, M.D., Ph.D., FACP6, Hans Christian Reinhardt, MD12, Bart L. Scott, MD3 and Nicolaus Kroeger, MD2

1Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, AL, Germany
2Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
3Fred Hutchinson Cancer Research Center, Seattle, WA
4Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany
5Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
6Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
7Department of Hematology, Centre Hospitalier Régional Universitaire (CHRU), Nancy, France
8Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
9Saint Louis Hospital, APHP, Paris, France
10Department of Hematology, Transplantation Division, Hopital Saint-Louis, Paris Cedex 10, France
11Department of Hematology, Centre Hospitalier Régional Universitaire (CHRU), Vandoeuvre-les-Nancy, France
12Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, NRW, Germany

Eleni Gavriilaki, MD, PhD1, Zoi Bousiou, MD, MSc2*, Ioannis Batsis3*, Anna Vardi4*, Despina Mallouri3*, Evdoxia Koravou5*, Georgia Konstantinidou6*, Nikolaos Spyridis, MD3*, Georgios Karavalakis6*, Vasileios Patriarcheas7*, Marianna Masmanidou6*, Tasoula Touloumenidou8*, Apostolia Papalexandri, MD9*, Christos Poziopoulos, MD10*, Evangelia Yannaki, MD6*, Ioanna Sakellari6*, Marianna Politou11* and Ioannis Papassotiriou, PhD12

12nd Propedeutic Department of Internal Medicine, George Papanicolaou General Hospital, Thessaloniki, Greece
2Hematology Dept.-BMT Unit, George Papanicolaou General Hospital, Thessaloniki, GRC
3Hematology Department – BMT Unit, G Papanikolaou Hospital, Thessaloniki, Greece
4G Papanicolaou Hospital, Thessaloniki, Greece
5Hematology Department & HCT Unit, G. Papanicolaou Hospital, Thessaloniki, GRC
6Hematology Dept. - BMT Unit, George Papanicolaou General Hospital, Thessaloniki, Greece
7Hematology Dept. - BMT Unit, George Papanicolaou General Hospital, THESSALONIKI, Greece
8Hematology Dept. - BMT Unit, Georgios Papanicolaou General Hospital, Thessaloniki, Greece
9George Papanicolaou General Hospital, Thessaloniki, Greece
10Department of Hematology, Metropolitan Hospital, Neo Faliro, Greece
11National and Kapodistrian University of Athens, Medical School, Athens, GRC
12First Department of Pediatrics, National and Kapodistrian University of Athens, School of Medicine, Athens, Attica, Greece

Mariana Nassif Kerbauy, MD1*, Fernanda Agostini Rocha, PhD2*, Leonardo Javier Arcuri, MD, PhD, MSc3*, Priscila Silva Cunegundes2*, Clarisse MARTINS Machado4*, Andreza Feitosa Ribeiro, MD5, Lucila Nassif Kerbauy, MD, PhD2, Luciana Cavalheiro Marti, PhD2* and Nelson Hamerschlak, MD, PhD6

1Hematology, Hospital Israelita Albert Einstein, São Paulo, BRA
2Hospital Israelita Albert Einstein, Sao Paulo, Brazil
3Albert Einstein Israelite Hospital, São Paulo, BRA
4University of Sao Paulo, Sao Paulo, BRA
5Hospital Israelita Albert Einstein, Sao Paulo, Sp, BRA
6Albert Einstein Israelite Hospital, Sao Paulo, Brazil

Yasmina Mozo, MD1*, Teresa Del Rosal, MD, PhD2,3*, Iker Falces-Romero, BsC4*, Karima Al-Akioui Sanz, MSc5*, Jorge Atucha, MLT3*, Lidia Pertiñez, MLT5*, Itsaso Losantos6*, Luisa Sisinni, MD, PhD7*, David Bueno, MD, PhD7*, Dolores Corral Sánchez, MD, PhD7*, Luz Yadira Bravo-Gallego, MD8,9,10*, Inmaculada Casas, MD, PhD11*, Talía Sainz, MD, PhD2*, Cristina Calvo, MD, PhD2,3* and Antonio Perez, MD, PhD5,7*

1Pediatric Hemato-Oncology Department, Hospital Universitario La Paz, Madrid, Spain
2General Pediatrics and Infectious Diseases Department, La Paz University Hospital, Madrid, Spain
3Pediatric Respiratory, Systemic and Neurological Infections & Host Immune Response, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain
4Clinical Microbiology and Parasitology Department, La Paz University Hospital, Madrid, Spain
5Translational Research in Pediatric Oncology, Hematopoietic Transplantation and Cell Therapy, Hospital La Paz Institute for Health Research-IdiPAZ, Madrid, Spain
6Statistics Department, La Paz University Hospital, Madrid, Spain
7Pediatric Hemato-Oncology Department, La Paz University Hospital, Madrid, Spain
8ERN-TransplantChild, La Paz University Hospital, Madrid, Spain
9Research on Comprehensive Care for Transplanted Children and Adolescents, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain
10Center for Biomedical Network Research on Rare Diseases (CIBERER U767), Madrid, Spain
11Respiratory Viruses and Influenza Unit, National Microbiology Center (ISCIII), Madrid, Spain

Zachariah Defilipp, MD1, Haesook T. Kim, PhD2, Nikolaos Spyrou, MD3*, Steven Kowalyk3*, Gilbert Eng3*, Rahnuma Beheshti3*, Janna Baez3*, Francis A. Ayuk, MD4*, Hannah Choe, MD5, Aaron Etra, MD3, Stephan Grupp, MD, PhD6, Elizabeth O Hexner, MD, MSTR7, William J. Hogan, MD8, Carrie L. Kitko, MD9, Muna Qayed, MD10, Ran Reshef, MD, MSc11, Ingrid Vasova, MD12*, Robert Zeiser, MD13, Rachel Young3*, James L.M. Ferrara, MD, DSc3, Ryotaro Nakamura, MD14, John Levine, MD3 and Yi-Bin Chen, MD, MS15

1Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA
2Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
3Icahn School of Medicine at Mount Sinai, New York, NY
4University Hospital Hamburg, Hamburg, Germany
5Division of Hematology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH
6Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
7University of Pennsylvania, Philadelphia
8Division of Hematology, Mayo Clinic, Rochester, MN
9Division of Pediatric Hematology/Oncology, Department of Pediatrics, Vanderbilt University, Nashville, TN
10Emory University and Children's Healthcare of Atlanta, Atlanta, GA
11Columbia University Medical Center, New York, NY
12University Hospital Erlangen, Prague 2, CZE
13University Medical Center Freiburg, Freiburg Im Breisgau, Germany
14Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope National Comprehensive Cancer Center, Duarte, CA
15Massachusetts General Hospital, Boston, MA

*signifies non-member of ASH